Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Specimen Handling 480 pembrolizumab 455 Magnetic Resonance Spectroscopy 420 Carboplatin 327 Cyclophosphamide 314 Cisplatin 271 Biopsy 271 Radiotherapy 244 Paclitaxel 229 Gemcitabine 227 Bevacizumab 213 Nivolumab 188 fludarabine 185 venetoclax 174 Drug Therapy 170 Blood Specimen Collection 158 Dexamethasone 157 Oxaliplatin 154 Injections 152 Capecitabine 151 Fluorouracil 144 Docetaxel 144 Radiosurgery 137 Standard of Care 135 Rituximab 125 Pemetrexed 117 durvalumab 115 Leucovorin 109 atezolizumab 107 Radiation 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × molgramostim × 1 year × Clear all

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡